Cargando…
The IlluminOss® photodynamic bone stabilization system for pathological osteolyses and fractures of the humerus: indications, advantages and limits in a series of 12 patients at 24 months of minimum follow‐up
BACKGROUND: Locked titanium nails are considered the reference treatment for metastatic bone lesions of the humerus in patients with aggressive histotypes, high risk of fracture or when estimated survival is lower than 6 months.Nevertheless, they are responsible for CT and MRI artifacts which interf...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798276/ https://www.ncbi.nlm.nih.gov/pubmed/33430839 http://dx.doi.org/10.1186/s12891-020-03927-6 |
_version_ | 1783635029696446464 |
---|---|
author | Zoccali, Carmine Attala, Dario Pugliese, Mattia di Uccio, Alessandra Scotto Baldi, Jacopo |
author_facet | Zoccali, Carmine Attala, Dario Pugliese, Mattia di Uccio, Alessandra Scotto Baldi, Jacopo |
author_sort | Zoccali, Carmine |
collection | PubMed |
description | BACKGROUND: Locked titanium nails are considered the reference treatment for metastatic bone lesions of the humerus in patients with aggressive histotypes, high risk of fracture or when estimated survival is lower than 6 months.Nevertheless, they are responsible for CT and MRI artifacts which interfere with postoperative radiotherapy and follow-up.The IlluminOss® is an intramedullary stabilization system which is introduced inside the humeral canal in a deflated state, and is then distended with a monomer which hardens after exposure to blue light,stabilizing the segment; it does not cause artifacts, allowing easier and more effective radiotherapy and follow-up. The aim of this study is to report our experience, indications, possible advantages and limitations of this stabilization system at 24 months of minimum follow-up in a series of 12 patients affected by pathological fractures or impending fractures of the humerus. METHODS: This is a retrospective case-series that included all patients who underwent surgery with the IlluminOss® Photodynamic Bone Stabilization System for pathological osteolyses and fractures of the humerus. Intraoperative and postoperative complications were valued. RESULTS: 12 patients and 13 procedures were included in the study. All surgeries were performed without intraoperative complications. No early postoperative complications were noted. The wounds healed in all cases and stitches were removed at two weeks from surgery, so the patients were able to perform chemotherapy after three weeks. All patients except one had a painless active range of motion which reached 90°.The VAS score was 7 preoperatively and 2.6 at one month from surgery. Pain relief was also associated to radiotherapy and chemotherapy. Unfortunately, two nail ruptures were reported at 4 and 12 months of follow-up. No artifacts were noted in the postoperative CT scans so the radiotherapy plans were easily performed without the need of dose compensation. CONCLUSIONS: The IlluminOss® intramedullary stabilization system can provide primary stability in humeral fractures and impending fractures;the surgical technique is easy and minimally invasive.Moreover,it does not present artifacts at postoperative imaging,probably giving a better chance to perform prompt radiotherapy and chemotherapy.However, randomized clinical studies are necessary to verify its potential strength and if precocious adjuvant radio- and chemotherapy are associated to a reduction of the local progression rate. |
format | Online Article Text |
id | pubmed-7798276 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-77982762021-01-12 The IlluminOss® photodynamic bone stabilization system for pathological osteolyses and fractures of the humerus: indications, advantages and limits in a series of 12 patients at 24 months of minimum follow‐up Zoccali, Carmine Attala, Dario Pugliese, Mattia di Uccio, Alessandra Scotto Baldi, Jacopo BMC Musculoskelet Disord Research Article BACKGROUND: Locked titanium nails are considered the reference treatment for metastatic bone lesions of the humerus in patients with aggressive histotypes, high risk of fracture or when estimated survival is lower than 6 months.Nevertheless, they are responsible for CT and MRI artifacts which interfere with postoperative radiotherapy and follow-up.The IlluminOss® is an intramedullary stabilization system which is introduced inside the humeral canal in a deflated state, and is then distended with a monomer which hardens after exposure to blue light,stabilizing the segment; it does not cause artifacts, allowing easier and more effective radiotherapy and follow-up. The aim of this study is to report our experience, indications, possible advantages and limitations of this stabilization system at 24 months of minimum follow-up in a series of 12 patients affected by pathological fractures or impending fractures of the humerus. METHODS: This is a retrospective case-series that included all patients who underwent surgery with the IlluminOss® Photodynamic Bone Stabilization System for pathological osteolyses and fractures of the humerus. Intraoperative and postoperative complications were valued. RESULTS: 12 patients and 13 procedures were included in the study. All surgeries were performed without intraoperative complications. No early postoperative complications were noted. The wounds healed in all cases and stitches were removed at two weeks from surgery, so the patients were able to perform chemotherapy after three weeks. All patients except one had a painless active range of motion which reached 90°.The VAS score was 7 preoperatively and 2.6 at one month from surgery. Pain relief was also associated to radiotherapy and chemotherapy. Unfortunately, two nail ruptures were reported at 4 and 12 months of follow-up. No artifacts were noted in the postoperative CT scans so the radiotherapy plans were easily performed without the need of dose compensation. CONCLUSIONS: The IlluminOss® intramedullary stabilization system can provide primary stability in humeral fractures and impending fractures;the surgical technique is easy and minimally invasive.Moreover,it does not present artifacts at postoperative imaging,probably giving a better chance to perform prompt radiotherapy and chemotherapy.However, randomized clinical studies are necessary to verify its potential strength and if precocious adjuvant radio- and chemotherapy are associated to a reduction of the local progression rate. BioMed Central 2021-01-11 /pmc/articles/PMC7798276/ /pubmed/33430839 http://dx.doi.org/10.1186/s12891-020-03927-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Zoccali, Carmine Attala, Dario Pugliese, Mattia di Uccio, Alessandra Scotto Baldi, Jacopo The IlluminOss® photodynamic bone stabilization system for pathological osteolyses and fractures of the humerus: indications, advantages and limits in a series of 12 patients at 24 months of minimum follow‐up |
title | The IlluminOss® photodynamic bone stabilization system for pathological osteolyses and fractures of the humerus: indications, advantages and limits in a series of 12 patients at 24 months of minimum follow‐up |
title_full | The IlluminOss® photodynamic bone stabilization system for pathological osteolyses and fractures of the humerus: indications, advantages and limits in a series of 12 patients at 24 months of minimum follow‐up |
title_fullStr | The IlluminOss® photodynamic bone stabilization system for pathological osteolyses and fractures of the humerus: indications, advantages and limits in a series of 12 patients at 24 months of minimum follow‐up |
title_full_unstemmed | The IlluminOss® photodynamic bone stabilization system for pathological osteolyses and fractures of the humerus: indications, advantages and limits in a series of 12 patients at 24 months of minimum follow‐up |
title_short | The IlluminOss® photodynamic bone stabilization system for pathological osteolyses and fractures of the humerus: indications, advantages and limits in a series of 12 patients at 24 months of minimum follow‐up |
title_sort | illuminoss® photodynamic bone stabilization system for pathological osteolyses and fractures of the humerus: indications, advantages and limits in a series of 12 patients at 24 months of minimum follow‐up |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798276/ https://www.ncbi.nlm.nih.gov/pubmed/33430839 http://dx.doi.org/10.1186/s12891-020-03927-6 |
work_keys_str_mv | AT zoccalicarmine theilluminossphotodynamicbonestabilizationsystemforpathologicalosteolysesandfracturesofthehumerusindicationsadvantagesandlimitsinaseriesof12patientsat24monthsofminimumfollowup AT attaladario theilluminossphotodynamicbonestabilizationsystemforpathologicalosteolysesandfracturesofthehumerusindicationsadvantagesandlimitsinaseriesof12patientsat24monthsofminimumfollowup AT pugliesemattia theilluminossphotodynamicbonestabilizationsystemforpathologicalosteolysesandfracturesofthehumerusindicationsadvantagesandlimitsinaseriesof12patientsat24monthsofminimumfollowup AT diuccioalessandrascotto theilluminossphotodynamicbonestabilizationsystemforpathologicalosteolysesandfracturesofthehumerusindicationsadvantagesandlimitsinaseriesof12patientsat24monthsofminimumfollowup AT baldijacopo theilluminossphotodynamicbonestabilizationsystemforpathologicalosteolysesandfracturesofthehumerusindicationsadvantagesandlimitsinaseriesof12patientsat24monthsofminimumfollowup AT zoccalicarmine illuminossphotodynamicbonestabilizationsystemforpathologicalosteolysesandfracturesofthehumerusindicationsadvantagesandlimitsinaseriesof12patientsat24monthsofminimumfollowup AT attaladario illuminossphotodynamicbonestabilizationsystemforpathologicalosteolysesandfracturesofthehumerusindicationsadvantagesandlimitsinaseriesof12patientsat24monthsofminimumfollowup AT pugliesemattia illuminossphotodynamicbonestabilizationsystemforpathologicalosteolysesandfracturesofthehumerusindicationsadvantagesandlimitsinaseriesof12patientsat24monthsofminimumfollowup AT diuccioalessandrascotto illuminossphotodynamicbonestabilizationsystemforpathologicalosteolysesandfracturesofthehumerusindicationsadvantagesandlimitsinaseriesof12patientsat24monthsofminimumfollowup AT baldijacopo illuminossphotodynamicbonestabilizationsystemforpathologicalosteolysesandfracturesofthehumerusindicationsadvantagesandlimitsinaseriesof12patientsat24monthsofminimumfollowup |